Evidence map›Paper›PMID 40639556›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2025

Plasmid diversity in Klebsiella pneumoniae ST307 co-producing KPC plus NDM recovered during the COVID-19 pandemic.

Sonia Alejandra Gomez, Florencia Martino, María Belén Sanz, Jenny Escalante, Juan Manuel de Mendieta, Celeste Lucero, Paola Ceriana, Fernando Pasteran, Alejandra Corso, María Soledad Ramirez and 1 more

Abstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. ConfrontingInfection and drug resistance · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sonia Alejandra GomezINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Florencia MartinoINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
María Belén SanzINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Jenny EscalanteCalifornia State University Fullerton, College of Natural Sciences and Mathematics, Department of Biological Science, Center for Applied Biotechnology Studies, Fullerton, CA 92831, USA.
Juan Manuel de MendietaINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina.
Celeste LuceroINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina.
Paola CerianaINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina.
Fernando PasteranINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina.
Alejandra CorsoINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina.
María Soledad RamirezCalifornia State University Fullerton, College of Natural Sciences and Mathematics, Department of Biological Science, Center for Applied Biotechnology Studies, Fullerton, CA 92831, USA. Electronic address: msramirez@fullerton.edu.
Diego FacconeINEI-ANLIS "Dr. Carlos G. Malbrán", Servicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos, Ciudad Autónoma de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.

Funding

Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter sppSC3GM125556 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI RAMIREZ, MARIA SOLEDAD · 2018 to 2025
$851k
NIGMS NIH HHS SC3 GM125556
6 · The paper itself

Abstract

The prevalence of carbapenemase-producing Klebsiella pneumoniae increased significantly during COVID-19 in Argentina, rising from 20 % in 2019 to 30 % in 2021. Additionally, there was a notable increase of K. pneumoniae ST307 co-producing KPC and NDM. We aimed to reveal the genetic structure of the plasmids harbored in six isolates of K. pneumoniae ST307 co-producing KPC and NDM and to expression levels of both carbapenemases in a cell. The isolates were collected between November 2020 and September 2021 and were selected according to: (i) diversity of allelic variant combinations: bla

Indexed as

Bacterial Proteinsbeta-LactamasesCOVID-19Klebsiella InfectionsKlebsiella pneumoniaePlasmidsAnti-Bacterial AgentsArgentinaDrug Resistance, Multiple, BacterialGenetic VariationHumansMicrobial Sensitivity TestsPandemicsSARS-CoV-2Whole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasescarbapenemaseAMRKlebsiella pneumoniaeKPCNDMPlasmidST307

Identifiers

PMID40639556
PMCPMC13175049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.